VASCULAR ACCESS SITE OCCLUSION

VASCULAR ACCESS SITE OCCLUSION was reported 79 times

These drug classes are most commonly taken by patients reporting VASCULAR ACCESS SITE OCCLUSION:

# Drug Count
0 Angiotensin Converting Enzyme Inhibitor [EPC] 10
1 Factor Xa Inhibitor [EPC] 10
2 Opioid Agonist [EPC] 9
3 Platinum-based Drug [EPC] 9
4 Corticosteroid [EPC] 8
5 Expectorant [EPC] 8
6 CD20-directed Cytolytic Antibody [EPC] 7
7 Nonsteroidal Anti-inflammatory Drug [EPC] 7
8 Tumor Necrosis Factor Blocker [EPC] 7
9 Proteasome Inhibitor [EPC] 6
10 HMG-CoA Reductase Inhibitor [EPC] 5
11 Integrin Receptor Antagonist [EPC] 5
12 Nitroimidazole Antimicrobial [EPC] 5
13 Lipid Emulsion [EPC] 4
14 Osmotic Laxative [EPC] 3
15 Proton Pump Inhibitor [EPC] 3
16 Calcium Channel Blocker [EPC] 2
17 Catecholamine [EPC] 2
18 Dihydropyridine Calcium Channel Blocker [EPC] 2
19 Folate Analog Metabolic Inhibitor [EPC] 2
20 Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] 2
21 Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] 2
22 Insulin Analog [EPC] 2
23 Phosphodiesterase 5 Inhibitor [EPC] 2
24 Prostacycline Vasodilator [EPC] 2
25 Provitamin D2 Compound [EPC] 2
26 Vitamin B12 [EPC] 2
27 Vitamin C [EPC] 2
28 Vitamin D Analog [EPC] 2
29 Vitamin D [EPC] 2
30 Vitamin D2 Analog [EPC] 2
31 alpha-Adrenergic Agonist [EPC] 2
32 beta-Adrenergic Agonist [EPC] 2
33 Alkaloid [EPC] 1
34 Amide Local Anesthetic [EPC] 1
35 Aminosalicylate [EPC] 1
36 Angiotensin 2 Receptor Blocker [EPC] 1
37 Antiarrhythmic [EPC] 1
38 Azole Antifungal [EPC] 1
39 Benzodiazepine Antagonist [EPC] 1
40 Benzodiazepine [EPC] 1
41 Bile Acid [EPC] 1
42 Calcium [EPC] 1
43 Central Nervous System Stimulant [EPC] 1
44 Central alpha-2 Adrenergic Agonist [EPC] 1
45 Cephalosporin Antibacterial [EPC] 1
46 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1
47 Endothelin Receptor Antagonist [EPC] 1
48 Epidermal Growth Factor Receptor Antagonist [EPC] 1
49 Ester Local Anesthetic [EPC] 1
50 GLP-1 Receptor Agonist [EPC] 1
51 Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] 1
52 Hepatitis C Virus NS5A Inhibitor [EPC] 1
53 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
54 Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
55 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
56 Histamine-1 Receptor Antagonist [EPC] 1
57 Histamine-2 Receptor Antagonist [EPC] 1
58 Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] 1
59 Interferon beta [EPC] 1
60 Microtubule Inhibitor [EPC] 1
61 Nitrofuran Antibacterial [EPC] 1
62 Non-Standardized Chemical Allergen [EPC] 1
63 Platelet Aggregation Inhibitor [EPC] 1
64 Potassium Channel Blocker [EPC] 1
65 Potassium Salt [EPC] 1
66 Prostacyclin Receptor Agonist [EPC] 1
67 RANK Ligand Inhibitor [EPC] 1
68 Sulfonamide Antimicrobial [EPC] 1
69 Thiazide Diuretic [EPC] 1
70 Vascular Endothelial Growth Factor Inhibitor [EPC] 1
71 Xanthine Oxidase Inhibitor [EPC] 1
72 alpha-Adrenergic Blocker [EPC] 1
73 beta-Adrenergic Blocker [EPC] 1
74 beta3-Adrenergic Agonist [EPC] 1